test

Early Drug Development Program

The Early Drug Development Program oversees research dedicated to studying new drugs that may become effective treatments for cancer. They conduct phase I clinical trials that are carefully designed safety studies of experimental drugs being given to patients for the first time.

Assistant Director, Development and Experimental Therapeutics
Paul Eder, MD
joseph.eder@yale.edu
(203) 737-5240 

Research Scientist, Developmental and Experimental Therapeutics
Juliane M. Jürgensmeier, PhD
Juliane.Juergensmeier@yale.edu
(203) 737-8370